Literature DB >> 7799403

Structure of a covalent DNA minor groove adduct with a pyrrolobenzodiazepine dimer: evidence for sequence-specific interstrand cross-linking.

T C Jenkins1, L H Hurley, S Neidle, D E Thurston.   

Abstract

The structure of the interstrand cross-linked adduct formed between a C8-C8'-linked pyrrolobenzodiazepine (PBD) dimer (DSB-120; 1,1'-(propane-1,3-diyldioxy)bis[(11aS)-7-methoxy-1,2,3,11a-t etrahydro-5H- pyrrolo[2,1-c][1,4]benzodiazepin-5-one]) and a self-complementary d(CICGATCICG)2 duplex has been determined from high-field 1D- and 2D-NMR data using a simulated annealing procedure. The refined structure supports earlier observations from solution NMR experiments and indicates that the covalently bound molecule spans six DNA base pairs in the minor groove, forming a symmetric cross-link between the spatially separated internal guanines and with active recognition of an embedded 5'-GATC bonding site. This result confirms that template-directed approaches are useful for the design of linked DNA-interactive PBD dimers with viable DNA cross-linking potential. Further, head-to-head connection of the PBD moieties results in an overall retention of 5'-GA bonding site preference for each alkylating PBD subunit. Structural analysis indicates that cross-link formation results in a localized perturbation of the DNA duplex, attributable in part to a mutual reduction in dynamic mobility or "covalent clamping" within the Gua4-Cyt7 base tract. However, ligand-induced distortion is confined to the Cyt7 and Ino8 residues on each strand. The Gua(N2)-Gua(N2) cross-link is stabilized by two directed H-bonds from the formed animal residues to N3 acceptor atoms of adenine bases on the 3'-side of each covalently modified guanine. Evidence for sequence-specific cross-linking with DSB-120 is provided by extended modeling studies which suggest that recognition of the favored d(.GATC.) motif is dominated by van der Waals steric factors, although electrostatic and H-bonded interaction terms also play a key role. This conclusion supports recent covalent footprinting studies revealing that this PBD dimer shows a selectivity for embedded base sequences of the type 5'-(pu/py)GATC(py/pu).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7799403     DOI: 10.1021/jm00052a012

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  18 in total

Review 1.  Using Genome Sequence to Enable the Design of Medicines and Chemical Probes.

Authors:  Alicia J Angelbello; Jonathan L Chen; Jessica L Childs-Disney; Peiyuan Zhang; Zi-Fu Wang; Matthew D Disney
Journal:  Chem Rev       Date:  2018-01-11       Impact factor: 60.622

2.  Linker Immolation Determines Cell Killing Activity of Disulfide-Linked Pyrrolobenzodiazepine Antibody-Drug Conjugates.

Authors:  Donglu Zhang; Thomas H Pillow; Yong Ma; Josefa Dela Cruz-Chuh; Katherine R Kozak; Jack D Sadowsky; Gail D Lewis Phillips; Jun Guo; Martine Darwish; Peter Fan; Jingtian Chen; Changrong He; Tao Wang; Hui Yao; Zijin Xu; Jinhua Chen; John Wai; Zhonghua Pei; Cornelis E C A Hop; S Cyrus Khojasteh; Peter S Dragovich
Journal:  ACS Med Chem Lett       Date:  2016-08-26       Impact factor: 4.345

Review 3.  Biosynthesis, synthesis, and biological activities of pyrrolobenzodiazepines.

Authors:  Barbara Gerratana
Journal:  Med Res Rev       Date:  2010-06-13       Impact factor: 12.944

4.  DNA Sequence Preference and Adduct Orientation of Pyrrolo[2,1-c][1,4]benzodiazepine Antitumor Agents.

Authors:  Khondaker M Rahman; Higia Vassoler; Colin H James; David E Thurston
Journal:  ACS Med Chem Lett       Date:  2010-08-13       Impact factor: 4.345

Review 5.  The clinical development of antibody-drug conjugates - lessons from leukaemia.

Authors:  Elias Jabbour; Shilpa Paul; Hagop Kantarjian
Journal:  Nat Rev Clin Oncol       Date:  2021-03-23       Impact factor: 66.675

6.  Preliminary pharmacokinetic and bioanalytical studies of SJG-136 (NSC 694501), a sequence-selective pyrrolobenzodiazepine dimer DNA-cross-linking agent.

Authors:  Gary P Wilkinson; James P Taylor; Steve Shnyder; Patricia Cooper; Phil W Howard; David E Thurston; Terence C Jenkins; Paul M Loadman
Journal:  Invest New Drugs       Date:  2004-08       Impact factor: 3.850

7.  Response of Staphylococcus aureus to subinhibitory concentrations of a sequence-selective, DNA minor groove cross-linking pyrrolobenzodiazepine dimer.

Authors:  Marie Doyle; Eva-Anne Feuerbaum; Keith R Fox; Jason Hinds; David E Thurston; Peter W Taylor
Journal:  J Antimicrob Chemother       Date:  2009-09-10       Impact factor: 5.790

Review 8.  Combining Biology and Chemistry for a New Take on Chemotherapy: Antibody-Drug Conjugates in Hematologic Malignancies.

Authors:  Helen Ma; Ahmed Sawas
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

9.  The minor groove-binding agent ELB-21 forms multiple interstrand and intrastrand covalent cross-links with duplex DNA and displays potent bactericidal activity against methicillin-resistant Staphylococcus aureus.

Authors:  Helena Rosado; Khondaker M Rahman; Eva-Anne Feuerbaum; Jason Hinds; David E Thurston; Peter W Taylor
Journal:  J Antimicrob Chemother       Date:  2011-03-03       Impact factor: 5.790

10.  The XPF-ERCC1 endonuclease and homologous recombination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136.

Authors:  Peter H Clingen; Inusha U De Silva; Peter J McHugh; Farid J Ghadessy; Michael J Tilby; David E Thurston; John A Hartley
Journal:  Nucleic Acids Res       Date:  2005-06-08       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.